fluorodeoxyglucose f18 has been researched along with semaglutide in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentsen, S; Binderup, T; Grandjean, CE; Jensen, JK; Kjaer, A; Ripa, RS | 1 |
1 other study(ies) available for fluorodeoxyglucose f18 and semaglutide
| Article | Year |
|---|---|
Semaglutide reduces vascular inflammation investigated by PET in a rabbit model of advanced atherosclerosis.
Topics: Animals; Atherosclerosis; Calcinosis; Fluorodeoxyglucose F18; Glucagon-Like Peptides; Inflammation; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Rabbits; Radionuclide Imaging; Radiopharmaceuticals | 2022 |